|
call loadScript javascripts\jsmol\core\package.js call loadScript javascripts\jsmol\core\core.z.js -- required by ClazzNode call loadScript javascripts\jsmol\J\awtjs2d\WebOutputChannel.js Jmol JavaScript applet jmolApplet0_object__4852992405960106__ initializing getValue debug = null getValue logLevel = null getValue allowjavascript = null AppletRegistry.checkIn(jmolApplet0_object__4852992405960106__) call loadScript javascripts\jsmol\core\corestate.z.js viewerOptions: { "name":"jmolApplet0_object","applet":true,"documentBase":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:15843","platform":"J.awtjs2d.Platform","fullName":"jmolApplet0_object__4852992405960106__","display":"jmolApplet0_canvas2d","signedApplet":"true","appletReadyCallback":"Jmol._readyCallback","statusListener":"[J.appletjs.Jmol.MyStatusListener object]","codeBase":"https://www.ebi.ac.uk/chebi/javascripts/jsmol/","syncId":"4852992405960106","bgcolor":"#000" } (C) 2012 Jmol Development Jmol Version: 13.2.7 $Date: 2013-10-01 11:35:15 -0500 (Tue, 01 Oct 2013) $ java.vendor: j2s java.version: 0.0 os.name: j2s Access: ALL memory: 0.0/0.0 processors available: 1 useCommandThread: false appletId:jmolApplet0_object (signed) starting HoverWatcher_1 getValue emulate = null defaults = "Jmol" getValue boxbgcolor = null getValue bgcolor = #000 backgroundColor = "#000" getValue ANIMFRAMECallback = null getValue APPLETREADYCallback = Jmol._readyCallback APPLETREADYCallback = "Jmol._readyCallback" getValue ATOMMOVEDCallback = null getValue CLICKCallback = null getValue ECHOCallback = null getValue ERRORCallback = null getValue EVALCallback = null getValue HOVERCallback = null getValue LOADSTRUCTCallback = null getValue MEASURECallback = null getValue MESSAGECallback = null getValue MINIMIZATIONCallback = null getValue PICKCallback = null getValue RESIZECallback = null getValue SCRIPTCallback = null getValue SYNCCallback = null getValue STRUCTUREMODIFIEDCallback = null getValue doTranslate = null language=en_US getValue popupMenu = null getValue script = null Jmol applet jmolApplet0_object__4852992405960106__ ready call loadScript javascripts\jsmol\core\corescript.z.js call loadScript javascripts\jsmol\J\script\FileLoadThread.js starting QueueThread0_2 script 1 started starting HoverWatcher_3 starting HoverWatcher_4 The Resolver thinks Mol Marvin 09090514133D starting HoverWatcher_5 Time for openFile( Marvin 09090514133D 54 53 0 0 0 0 999 V2000 36.2091 -26.5468 0.6486 C 0 0 0 0 0 0 0 0 0 0 0 0 36.5673 -25.5189 -0.4074 C 0 0 0 0 0 0 0 0 0 0 0 0 37.4159 -24.4042 0.2255 C 0 0 0 0 0 0 0 0 0 0 0 0 37.7493 -23.3367 -0.8332 C 0 0 0 0 0 0 0 0 0 0 0 0 38.6640 -22.2831 -0.2257 C 0 0 0 0 0 0 0 0 0 0 0 0 40.0061 -22.3813 -0.3255 C 0 0 0 0 0 0 0 0 0 0 0 0 40.6567 -23.5485 -1.0560 C 0 0 0 0 0 0 0 0 0 0 0 0 41.4393 -23.0363 -2.2552 C 0 0 0 0 0 0 0 0 0 0 0 0 42.7867 -23.0932 -2.2843 C 0 0 0 0 0 0 0 0 0 0 0 0 43.5900 -23.6747 -1.1286 C 0 0 0 0 0 0 0 0 0 0 0 0 44.8826 -24.2605 -1.6737 C 0 0 0 0 0 0 0 0 0 0 0 0 45.4701 -25.3305 -1.0998 C 0 0 0 0 0 0 0 0 0 0 0 0 44.8751 -26.0025 0.1290 C 0 0 0 0 0 0 0 0 0 0 0 0 45.6948 -27.2381 0.4807 C 0 0 0 0 0 0 0 0 0 0 0 0 45.1574 -28.2428 1.2025 C 0 0 0 0 0 0 0 0 0 0 0 0 43.7225 -28.1759 1.6968 C 0 0 0 0 0 0 0 0 0 0 0 0 42.7567 -28.6628 0.5995 C 0 0 0 0 0 0 0 0 0 0 0 0 41.3027 -28.4614 1.0550 C 0 0 0 0 0 0 0 0 0 0 0 0 41.0012 -26.9575 1.1887 C 0 0 0 0 0 0 0 0 0 0 0 0 39.5549 -26.7575 1.6658 C 0 0 0 0 0 0 0 0 0 0 0 0 35.7561 -26.1902 1.7187 O 0 0 0 0 0 0 0 0 0 0 0 0 36.3832 -27.8765 0.3862 O 0 0 0 0 0 0 0 0 0 0 0 0 35.6300 -25.0850 -0.8288 H 0 0 0 0 0 0 0 0 0 0 0 0 37.1460 -26.0164 -1.2211 H 0 0 0 0 0 0 0 0 0 0 0 0 38.3626 -24.8408 0.6226 H 0 0 0 0 0 0 0 0 0 0 0 0 36.8443 -23.9332 1.0597 H 0 0 0 0 0 0 0 0 0 0 0 0 36.8092 -22.8484 -1.1831 H 0 0 0 0 0 0 0 0 0 0 0 0 38.2651 -23.8149 -1.6991 H 0 0 0 0 0 0 0 0 0 0 0 0 38.3276 -21.3767 0.3307 H 0 0 0 0 0 0 0 0 0 0 0 0 40.5493 -21.5421 0.1696 H 0 0 0 0 0 0 0 0 0 0 0 0 39.8661 -24.2540 -1.4049 H 0 0 0 0 0 0 0 0 0 0 0 0 41.3499 -24.0797 -0.3620 H 0 0 0 0 0 0 0 0 0 0 0 0 40.9951 -22.5885 -3.1753 H 0 0 0 0 0 0 0 0 0 0 0 0 43.2188 -22.6769 -3.2247 H 0 0 0 0 0 0 0 0 0 0 0 0 42.9986 -24.4765 -0.6268 H 0 0 0 0 0 0 0 0 0 0 0 0 43.8254 -22.8698 -0.3930 H 0 0 0 0 0 0 0 0 0 0 0 0 45.4410 -23.8769 -2.5600 H 0 0 0 0 0 0 0 0 0 0 0 0 46.4062 -25.6456 -1.6183 H 0 0 0 0 0 0 0 0 0 0 0 0 43.8224 -26.3029 -0.0856 H 0 0 0 0 0 0 0 0 0 0 0 0 44.8913 -25.2889 0.9864 H 0 0 0 0 0 0 0 0 0 0 0 0 46.7567 -27.4191 0.1909 H 0 0 0 0 0 0 0 0 0 0 0 0 45.8643 -29.0868 1.3819 H 0 0 0 0 0 0 0 0 0 0 0 0 43.4805 -27.1207 1.9660 H 0 0 0 0 0 0 0 0 0 0 0 0 43.6193 -28.8233 2.5993 H 0 0 0 0 0 0 0 0 0 0 0 0 42.9350 -29.7463 0.4029 H 0 0 0 0 0 0 0 0 0 0 0 0 42.9343 -28.0806 -0.3356 H 0 0 0 0 0 0 0 0 0 0 0 0 41.1524 -28.9588 2.0422 H 0 0 0 0 0 0 0 0 0 0 0 0 40.6137 -28.9121 0.3021 H 0 0 0 0 0 0 0 0 0 0 0 0 41.1351 -26.4626 0.1978 H 0 0 0 0 0 0 0 0 0 0 0 0 41.7008 -26.5031 1.9294 H 0 0 0 0 0 0 0 0 0 0 0 0 38.8905 -26.6025 0.7831 H 0 0 0 0 0 0 0 0 0 0 0 0 39.5035 -25.8635 2.3314 H 0 0 0 0 0 0 0 0 0 0 0 0 39.2209 -27.6614 2.2282 H 0 0 0 0 0 0 0 0 0 0 0 0 36.7511 -28.1729 -0.5134 H 0 0 0 0 0 0 0 0 0 0 0 0 1 22 1 0 0 0 0 1 21 2 0 0 0 0 1 2 1 0 0 0 0 2 3 1 0 0 0 0 23 2 1 0 0 0 0 24 2 1 0 0 0 0 3 4 1 0 0 0 0 25 3 1 0 0 0 0 26 3 1 0 0 0 0 4 5 1 0 0 0 0 27 4 1 0 0 0 0 28 4 1 0 0 0 0 5 6 2 0 0 0 0 29 5 1 0 0 0 0 6 7 1 0 0 0 0 30 6 1 0 0 0 0 7 8 1 0 0 0 0 31 7 1 0 0 0 0 32 7 1 0 0 0 0 8 9 2 0 0 0 0 33 8 1 0 0 0 0 9 10 1 0 0 0 0 34 9 1 0 0 0 0 10 11 1 0 0 0 0 35 10 1 0 0 0 0 36 10 1 0 0 0 0 11 12 2 0 0 0 0 37 11 1 0 0 0 0 12 13 1 0 0 0 0 38 12 1 0 0 0 0 13 14 1 0 0 0 0 39 13 1 0 0 0 0 40 13 1 0 0 0 0 14 15 2 0 0 0 0 41 14 1 0 0 0 0 15 16 1 0 0 0 0 42 15 1 0 0 0 0 16 17 1 0 0 0 0 43 16 1 0 0 0 0 44 16 1 0 0 0 0 17 18 1 0 0 0 0 45 17 1 0 0 0 0 46 17 1 0 0 0 0 18 19 1 0 0 0 0 47 18 1 0 0 0 0 48 18 1 0 0 0 0 19 20 1 0 0 0 0 49 19 1 0 0 0 0 50 19 1 0 0 0 0 51 20 1 0 0 0 0 52 20 1 0 0 0 0 53 20 1 0 0 0 0 54 22 1 0 0 0 0 M END): 20 ms reading 54 atoms ModelSet: haveSymmetry:false haveUnitcells:false haveFractionalCoord:false 1 model in this collection. Use getProperty "modelInfo" or getProperty "auxiliaryInfo" to inspect them. Default Van der Waals type for model set to Babel 54 atoms created ModelSet: not autobonding; use forceAutobond=true to force automatic bond creation Script completed Jmol script terminated
|
Arachidonic acid (AA, sometimes ARA) is a polyunsaturated omega−6 fatty acid 20:4(ω−6), or 20:4(5,8,11,14). If its precursors or diet contains linoleic acid it is formed by biosynthesis and can be deposited in animal fats. It is a precursor in the formation of leukotrienes, prostaglandins, and thromboxanes.
Together with omega−3 fatty acids and other omega−6 fatty acids, arachidonic acid provides energy for body functions, contributes to cell membrane structure, and participates in the synthesis of eicosanoids, which have numerous roles in physiology as signaling molecules.
Its name derives from the ancient Greek neologism arachis 'peanut', although peanut oil does not contain any arachidonic acid. Arachidonate is the name of the derived carboxylate anion (conjugate base of the acid), salts, and some esters.
|
Read full article at Wikipedia
|
InChI=1S/C20H32O2/c1- 2- 3- 4- 5- 6- 7- 8- 9- 10- 11- 12- 13- 14- 15- 16- 17- 18- 19- 20(21) 22/h6- 7,9- 10,12- 13,15- 16H,2- 5,8,11,14,17- 19H2,1H3,(H,21,22) /b7- 6- ,10- 9- ,13- 12- ,16- 15- |
YZXBAPSDXZZRGB-DOFZRALJSA-N |
CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O |
|
Mus musculus
(NCBI:txid10090)
|
See:
MetaboLights Study
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
Daphnia galeata
(NCBI:txid27404)
|
See:
Is the fatty acid composition of Daphnia galeata determined by the fatty acid composition of the ingested diet?Weers P.M.M., Siewertsen K., and Gulati R.D.Freshwater Biology (1997), 38, 731-738
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
EC 3.1.1.1 (carboxylesterase) inhibitor
Any EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that inhibits the action of carboxylesterase (EC 3.1.1.1 ).
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via icosatetraenoic acid )
Daphnia galeata metabolite
A Daphnia metabolite produced by the species Daphnia galeata.
Caenorhabditis elegans metabolite
A nematode metabolite produced by Caenorhabditis elegans.
(via icosatetraenoic acid )
|
|
View more via ChEBI Ontology
Outgoing
|
arachidonic acid
(CHEBI:15843)
has parent hydride
(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraene
(CHEBI:37834)
arachidonic acid
(CHEBI:15843)
has role
Daphnia galeata metabolite
(CHEBI:83038)
arachidonic acid
(CHEBI:15843)
has role
EC 3.1.1.1 (carboxylesterase) inhibitor
(CHEBI:78444)
arachidonic acid
(CHEBI:15843)
has role
human metabolite
(CHEBI:77746)
arachidonic acid
(CHEBI:15843)
has role
mouse metabolite
(CHEBI:75771)
arachidonic acid
(CHEBI:15843)
is a
ω−6 fatty acid
(CHEBI:36009)
arachidonic acid
(CHEBI:15843)
is a
icosa-5,8,11,14-tetraenoic acid
(CHEBI:36306)
arachidonic acid
(CHEBI:15843)
is a
long-chain fatty acid
(CHEBI:15904)
arachidonic acid
(CHEBI:15843)
is conjugate acid of
arachidonate
(CHEBI:32395)
|
|
Incoming
|
(5Z,8R,9R,11Z,14Z)-8,9-dihydroxyicosatrienoic acid
(CHEBI:138586)
has functional parent
arachidonic acid
(CHEBI:15843)
(5Z,8S,9S,11Z,14Z)-8,9-dihydroxyicosatrienoic acid
(CHEBI:138585)
has functional parent
arachidonic acid
(CHEBI:15843)
(5Z,8Z,11R,12R,14Z)-11,12-dihydroxyicosatrienoic acid
(CHEBI:138593)
has functional parent
arachidonic acid
(CHEBI:15843)
(5Z,8Z,11S,12S,14Z)-11,12-dihydroxyicosatrienoic acid
(CHEBI:138594)
has functional parent
arachidonic acid
(CHEBI:15843)
(5Z,8Z,11Z,14R,15R)-14,15-dihydroxyicosatrienoic acid
(CHEBI:138591)
has functional parent
arachidonic acid
(CHEBI:15843)
(5Z,8Z,11Z,14S,15S)-14,15-dihydroxyicosatrienoic acid
(CHEBI:138592)
has functional parent
arachidonic acid
(CHEBI:15843)
1,2-diarachidonoyl-sn-glycerol
(CHEBI:77125)
has functional parent
arachidonic acid
(CHEBI:15843)
1-(1Z)-hexadecenyl-2-arachidonoyl-sn-glycero-3-phosphocholine
(CHEBI:77292)
has functional parent
arachidonic acid
(CHEBI:15843)
1-(1Z-hexadecenyl)-2-arachidonoyl-sn-glycero-3-phosphoethanolamine
(CHEBI:84527)
has functional parent
arachidonic acid
(CHEBI:15843)
1-(1Z-octadecenyl)-2-arachidonoyl-sn-glycero-3-phosphoethanolamine
(CHEBI:79207)
has functional parent
arachidonic acid
(CHEBI:15843)
1-(1Z-octadecenyl)-2-arachidonoyl-sn-glycero-3-phosphoserine
(CHEBI:79211)
has functional parent
arachidonic acid
(CHEBI:15843)
1-(1Z-octadecenyl)-sn-glycero-3-phospho-(N-arachidonoyl)ethanolamine
(CHEBI:138096)
has functional parent
arachidonic acid
(CHEBI:15843)
1-(9Z-octadecenyl)-2-arachidonoyl-sn-glycero-3-phosphate
(CHEBI:85672)
has functional parent
arachidonic acid
(CHEBI:15843)
1-O-alkyl-2-O-arachidonoyl-sn-glycero-3-phosphocholine
(CHEBI:28894)
has functional parent
arachidonic acid
(CHEBI:15843)
1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine zwitterion
(CHEBI:76251)
has functional parent
arachidonic acid
(CHEBI:15843)
1-O-arachidonoyl-N-acetylsphingosine
(CHEBI:76080)
has functional parent
arachidonic acid
(CHEBI:15843)
1-[(1Z)-octadecenyl]-2-[(5Z,8Z,11Z,14Z)-icosatetraenoyl]-sn-glycero-3-phosphocholine
(CHEBI:84828)
has functional parent
arachidonic acid
(CHEBI:15843)
1-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-2-[(9Z,12Z)-octadecadienoyl]-sn-glycero-3-phosphocholine
(CHEBI:86184)
has functional parent
arachidonic acid
(CHEBI:15843)
1-[(7Z)-hexadecenoyl]-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine
(CHEBI:64505)
has functional parent
arachidonic acid
(CHEBI:15843)
1-[(9Z)-hexadecenoyl]-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine
(CHEBI:84816)
has functional parent
arachidonic acid
(CHEBI:15843)
1-[(9Z)-octadecenyl]-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine
(CHEBI:84827)
has functional parent
arachidonic acid
(CHEBI:15843)
1-[(9Z)-tetradecenoyl]-2-[(5Z,8Z,11Z,14Z)-icosatetraenoyl]-sn-glycerol
(CHEBI:86977)
has functional parent
arachidonic acid
(CHEBI:15843)
1-[(9Z,12Z)-octadecadienoyl]-2-[(5Z,8Z,11Z,14Z)-icosatetraenoyl]-sn-glycero-3-phosphocholine
(CHEBI:84563)
has functional parent
arachidonic acid
(CHEBI:15843)
1-acyl-2-arachidonoyl-sn-glycero-3-phosphate
(CHEBI:75112)
has functional parent
arachidonic acid
(CHEBI:15843)
1-acyl-2-arachidonoyl-sn-glycero-3-phosphocholine
(CHEBI:75063)
has functional parent
arachidonic acid
(CHEBI:15843)
1-acyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine zwitterion
(CHEBI:75067)
has functional parent
arachidonic acid
(CHEBI:15843)
1-arachidonoyl-2-oleoyl-sn-glycero-3-phosphate
(CHEBI:75141)
has functional parent
arachidonic acid
(CHEBI:15843)
1-arachidonoyl-2-oleoylglycerol
(CHEBI:75611)
has functional parent
arachidonic acid
(CHEBI:15843)
1-arachidonoyl-2-palmitoyl-sn-glycero-3-phosphocholine
(CHEBI:77694)
has functional parent
arachidonic acid
(CHEBI:15843)
1-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol
(CHEBI:83053)
has functional parent
arachidonic acid
(CHEBI:15843)
1-arachidonoyl-sn-glycero-3-phospho-L-serine
(CHEBI:85435)
has functional parent
arachidonic acid
(CHEBI:15843)
1-arachidonoyl-sn-glycero-3-phospho-L-serine(1−)
(CHEBI:84723)
has functional parent
arachidonic acid
(CHEBI:15843)
1-arachidonoyl-sn-glycero-3-phosphocholine
(CHEBI:74344)
has functional parent
arachidonic acid
(CHEBI:15843)
1-arachidonoyl-sn-glycero-3-phosphoethanolamine
(CHEBI:64395)
has functional parent
arachidonic acid
(CHEBI:15843)
1-arachidonoyl-sn-glycerol 3-phosphate
(CHEBI:73792)
has functional parent
arachidonic acid
(CHEBI:15843)
1-arachidonoylglycerol
(CHEBI:75612)
has functional parent
arachidonic acid
(CHEBI:15843)
1-arachidonoylglycerone 3-phosphate
(CHEBI:78175)
has functional parent
arachidonic acid
(CHEBI:15843)
1-heptadecanoyl-2-arachidonoyl-sn-glycero-3-phosphocholine
(CHEBI:84470)
has functional parent
arachidonic acid
(CHEBI:15843)
1-heptadecanoyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine
(CHEBI:85408)
has functional parent
arachidonic acid
(CHEBI:15843)
1-heptadecanoyl-2-arachidonoyl-sn-glycero-3-phosphoserine
(CHEBI:85400)
has functional parent
arachidonic acid
(CHEBI:15843)
1-hexadecanoyl-2-(5Z,8Z,11Z,14Z-icosatetraenoyl)-sn-glycero-3-phosphoethanolamine
(CHEBI:73117)
has functional parent
arachidonic acid
(CHEBI:15843)
1-icosanoyl-2-arachidonoyl-sn-glycerol
(CHEBI:87223)
has functional parent
arachidonic acid
(CHEBI:15843)
1-oleoyl-2-arachidonoyl-sn-glycero-3-phosphate
(CHEBI:75118)
has functional parent
arachidonic acid
(CHEBI:15843)
1-oleoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol
(CHEBI:82762)
has functional parent
arachidonic acid
(CHEBI:15843)
1-oleoyl-2-arachidonoyl-sn-glycero-3-phospho-L-serine
(CHEBI:75099)
has functional parent
arachidonic acid
(CHEBI:15843)
1-oleoyl-2-arachidonoyl-sn-glycerol
(CHEBI:75449)
has functional parent
arachidonic acid
(CHEBI:15843)
1-oleoyl-2-arachidonoyl-sn-glycerol-3-phosphoethanolamine
(CHEBI:75169)
has functional parent
arachidonic acid
(CHEBI:15843)
1-palmitoyl-2-arachidonoyl-sn-glycero-3-phospho-(1'-sn-glycerol)
(CHEBI:84526)
has functional parent
arachidonic acid
(CHEBI:15843)
1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine
(CHEBI:73003)
has functional parent
arachidonic acid
(CHEBI:15843)
1-palmitoyl-2-arachidonoyl-sn-glycerol
(CHEBI:77096)
has functional parent
arachidonic acid
(CHEBI:15843)
1-palmityl-2-arachidonoyl-sn-glycero-3-phosphate
(CHEBI:77355)
has functional parent
arachidonic acid
(CHEBI:15843)
1-palmityl-2-arachidonoyl-sn-glycerol
(CHEBI:77184)
has functional parent
arachidonic acid
(CHEBI:15843)
1-pentadecanoyl-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine
(CHEBI:86344)
has functional parent
arachidonic acid
(CHEBI:15843)
1-stearoyl-2-arachidonoyl-3-oleoyl-sn-glycerol
(CHEBI:75729)
has functional parent
arachidonic acid
(CHEBI:15843)
1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1ʼ-sn-glycerol)
(CHEBI:75646)
has functional parent
arachidonic acid
(CHEBI:15843)
1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1D-myo-inositol 3,4,5-triphosphate)
(CHEBI:83980)
has functional parent
arachidonic acid
(CHEBI:15843)
1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol
(CHEBI:84153)
has functional parent
arachidonic acid
(CHEBI:15843)
1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol 4,5-biphosphate
(CHEBI:77276)
has functional parent
arachidonic acid
(CHEBI:15843)
1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol 4-phosphate
(CHEBI:77271)
has functional parent
arachidonic acid
(CHEBI:15843)
1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-1D-myo-inositol 5-phosphate
(CHEBI:77345)
has functional parent
arachidonic acid
(CHEBI:15843)
1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphoethanolamine
(CHEBI:79110)
has functional parent
arachidonic acid
(CHEBI:15843)
1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphoserine
(CHEBI:79113)
has functional parent
arachidonic acid
(CHEBI:15843)
1-stearoyl-2-arachidonoyl-sn-glycerol
(CHEBI:75728)
has functional parent
arachidonic acid
(CHEBI:15843)
1-stearoyl-2-arachidonoylglycerol
(CHEBI:83288)
has functional parent
arachidonic acid
(CHEBI:15843)
1-stearoyl-2-arachidonoylphosphatidic acid
(CHEBI:84165)
has functional parent
arachidonic acid
(CHEBI:15843)
1-tetradecanoyl-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine
(CHEBI:86102)
has functional parent
arachidonic acid
(CHEBI:15843)
10-HETE
(CHEBI:134453)
has functional parent
arachidonic acid
(CHEBI:15843)
11,12-epoxy-20-hydroxy-(5Z,8Z,14Z)-icosatrienoic acid
(CHEBI:138273)
has functional parent
arachidonic acid
(CHEBI:15843)
13-HETE
(CHEBI:137345)
has functional parent
arachidonic acid
(CHEBI:15843)
14,15-epoxy-20-hydroxy-(5Z,8Z,11Z)-icosatrienoic acid
(CHEBI:138274)
has functional parent
arachidonic acid
(CHEBI:15843)
17,18-DiHETE
(CHEBI:88349)
has functional parent
arachidonic acid
(CHEBI:15843)
18(R)-HETE
(CHEBI:91132)
has functional parent
arachidonic acid
(CHEBI:15843)
19(S)-HETE
(CHEBI:34185)
has functional parent
arachidonic acid
(CHEBI:15843)
19-HETE
(CHEBI:63998)
has functional parent
arachidonic acid
(CHEBI:15843)
2-arachidonoyl-sn-glycero-3-phosphate
(CHEBI:79059)
has functional parent
arachidonic acid
(CHEBI:15843)
2-arachidonoyl-sn-glycero-3-phospho-L-serine
(CHEBI:78703)
has functional parent
arachidonic acid
(CHEBI:15843)
2-arachidonoyl-sn-glycero-3-phosphocholine
(CHEBI:76079)
has functional parent
arachidonic acid
(CHEBI:15843)
2-arachidonoyl-sn-glycero-3-phosphoethanolamine zwitterion
(CHEBI:76091)
has functional parent
arachidonic acid
(CHEBI:15843)
2-arachidonoylglycerol
(CHEBI:52392)
has functional parent
arachidonic acid
(CHEBI:15843)
2-arachidonyl-sn-glycero-3-phosphoethanolamine
(CHEBI:72741)
has functional parent
arachidonic acid
(CHEBI:15843)
20-HETE
(CHEBI:34306)
has functional parent
arachidonic acid
(CHEBI:15843)
20-oxoarachidonic acid
(CHEBI:76965)
has functional parent
arachidonic acid
(CHEBI:15843)
5,6-epoxy-20-hydroxy-(8Z,11Z,14Z)-icosatrienoic acid
(CHEBI:138271)
has functional parent
arachidonic acid
(CHEBI:15843)
7-HETE
(CHEBI:137344)
has functional parent
arachidonic acid
(CHEBI:15843)
8(S),15(S)-DiHETE
(CHEBI:136485)
has functional parent
arachidonic acid
(CHEBI:15843)
8(S),15(S)-DiHPETE
(CHEBI:136400)
has functional parent
arachidonic acid
(CHEBI:15843)
8,9-epoxy-20-hydroxy-(5Z,11Z,14Z)-icosatrienoic acid
(CHEBI:138272)
has functional parent
arachidonic acid
(CHEBI:15843)
9-oxo-ETE
(CHEBI:136365)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoyl-γ-aminobutyric acid
(CHEBI:132722)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoyl-1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
(CHEBI:85784)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoyl-1-oleoyl-sn-glycero-3-phosphoethanolamine
(CHEBI:85666)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoyl-2-oxoserotonin
(CHEBI:132256)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoyl-sn-glycero-3-phosphoethanolamine
(CHEBI:85671)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoyl-L-alanine
(CHEBI:132708)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoyl-L-leucine
(CHEBI:136683)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoyl-L-phenylalanine
(CHEBI:136606)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoyl-L-serine
(CHEBI:143514)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoylglycine
(CHEBI:58961)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoylphosphatidylethanolamine
(CHEBI:52571)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoylphytosphingosine
(CHEBI:85207)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoylserotonin
(CHEBI:132255)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoylsphinganine
(CHEBI:85206)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoylsphingosine
(CHEBI:85198)
has functional parent
arachidonic acid
(CHEBI:15843)
N-arachidonoyltaurine
(CHEBI:132506)
has functional parent
arachidonic acid
(CHEBI:15843)
AACOCF3
(CHEBI:2341)
has functional parent
arachidonic acid
(CHEBI:15843)
anandamide
(CHEBI:2700)
has functional parent
arachidonic acid
(CHEBI:15843)
arachidonoyl amine
(CHEBI:137830)
has functional parent
arachidonic acid
(CHEBI:15843)
arachidonoyl bioconjugate
(CHEBI:76180)
has functional parent
arachidonic acid
(CHEBI:15843)
Arachidonoyl dopamine
(CHEBI:31231)
has functional parent
arachidonic acid
(CHEBI:15843)
arachidonoyl-CoA
(CHEBI:15514)
has functional parent
arachidonic acid
(CHEBI:15843)
arachidonoyl-containing glycerolipid
(CHEBI:90077)
has functional parent
arachidonic acid
(CHEBI:15843)
arachidonoylcholine
(CHEBI:133694)
has functional parent
arachidonic acid
(CHEBI:15843)
arachidonyl-2'-chloroethylamide
(CHEBI:191854)
has functional parent
arachidonic acid
(CHEBI:15843)
CDP-1,2-diarachidonoyl-sn-glycerol
(CHEBI:85835)
has functional parent
arachidonic acid
(CHEBI:15843)
CDP-1-palmitoyl-2-arachidonoyl-sn-glycerol
(CHEBI:85830)
has functional parent
arachidonic acid
(CHEBI:15843)
CDP-1-stearoyl-2-arachidonoyl-sn-glycerol
(CHEBI:85829)
has functional parent
arachidonic acid
(CHEBI:15843)
cholesteryl arachidonate
(CHEBI:82751)
has functional parent
arachidonic acid
(CHEBI:15843)
DHET
(CHEBI:64005)
has functional parent
arachidonic acid
(CHEBI:15843)
EET
(CHEBI:64007)
has functional parent
arachidonic acid
(CHEBI:15843)
ethyl arachidonate
(CHEBI:84873)
has functional parent
arachidonic acid
(CHEBI:15843)
lipoxin
(CHEBI:6497)
has functional parent
arachidonic acid
(CHEBI:15843)
methyl arachidonate
(CHEBI:78033)
has functional parent
arachidonic acid
(CHEBI:15843)
1-arachidonyl-2-palmityl-sn-glycero-3-phosphocholine
(CHEBI:77695)
is a
arachidonic acid
(CHEBI:15843)
arachidonate
(CHEBI:32395)
is conjugate base of
arachidonic acid
(CHEBI:15843)
|
(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid
|
(5Z,8Z,11Z,14Z)-5,8,11,14-icosatetraenoic acid
|
NIST Chemistry WebBook
|
(5Z,8Z,11Z,14Z)-Icosatetraenoic acid
|
KEGG COMPOUND
|
AA
|
ChEBI
|
all-cis-5,8,11,14-eicosatetraenoic acid
|
ChEBI
|
ARA
|
ChEBI
|
Arachidonate
|
KEGG COMPOUND
|
Arachidonic acid
|
KEGG COMPOUND
|
ARACHIDONIC ACID
|
PDBeChem
|
Arachidonsäure
|
ChEBI
|
cis-5,8,11,14-Eicosatetraenoic acid
|
KEGG COMPOUND
|
cis-Δ5,8,11,14-eicosatetraenoic acid
|
ChEBI
|
1913991
|
Reaxys Registry Number
|
Reaxys
|
506-32-1
|
CAS Registry Number
|
KEGG COMPOUND
|
506-32-1
|
CAS Registry Number
|
ChemIDplus
|
506-32-1
|
CAS Registry Number
|
NIST Chemistry WebBook
|
58972
|
Gmelin Registry Number
|
Gmelin
|
Bourgeois EA, Subramaniam S, Cheng TY, De Jong A, Layre E, Ly D, Salimi M, Legaspi A, Modlin RL, Salio M, Cerundolo V, Moody DB, Ogg G (2015) Bee venom processes human skin lipids for presentation by CD1a. The Journal of experimental medicine 212, 149-163 [PubMed:25584012] [show Abstract] Venoms frequently co-opt host immune responses, so study of their mode of action can provide insight into novel inflammatory pathways. Using bee and wasp venom responses as a model system, we investigated whether venoms contain CD1-presented antigens. Here, we show that venoms activate human T cells via CD1a proteins. Whereas CD1 proteins typically present lipids, chromatographic separation of venoms unexpectedly showed that stimulatory factors partition into protein-containing fractions. This finding was explained by demonstrating that bee venom-derived phospholipase A2 (PLA2) activates T cells through generation of small neoantigens, such as free fatty acids and lysophospholipids, from common phosphodiacylglycerides. Patient studies showed that injected PLA2 generates lysophospholipids within human skin in vivo, and polyclonal T cell responses are dependent on CD1a protein and PLA2. These findings support a previously unknown skin immune response based on T cell recognition of CD1a proteins and lipid neoantigen generated in vivo by phospholipases. The findings have implications for skin barrier sensing by T cells and mechanisms underlying phospholipase-dependent inflammatory skin disease. | Agostoni C (2008) Role of long-chain polyunsaturated fatty acids in the first year of life. Journal of pediatric gastroenterology and nutrition 47 Suppl 2, S41-4 [PubMed:18931599] [show Abstract] The 2 most abundant long-chain polyunsaturated fatty acids (LCPUFAs) in the brain are docosahexaenoic acid (DHA) and arachidonic acid (ARA), where they have a functional and structural role in infant development. DHA is concentrated in the prefrontal cortex, which is important for association and short-term memory, and in some retinal cells. Concentrations of PUFAs in human breast milk are relatively consistent during the first year of life, and studies have shown that breast-fed infants have a greater mean weight percentage of DHA and a greater proportion of DHA in their red blood cells and brain cortex than formula-fed infants. Furthermore, cortex DHA in breast-fed infants increases with age, probably due to the length of feeding. Maternal supplementation with cod liver oil, which is rich in DHA and eicosapentaenoic acid, improved children's intelligence quotient compared with corn-oil supplementation by 4 years of age. The LCPUFA content of human breast milk is affected by a number of factors, including diet, gestational age, parity, and smoking. Supplementation of formula feed with DHA and ARA results in infant development that is similar to breast-feeding, and may have benefits on blood pressure in later childhood. The beneficial effects of LCPUFA supplementation on visual acuity continue after weaning irrespective of the type of diet. The long-term effects and duration of supplementation of breast- and formula-fed infants requires further investigation. | Rapoport SI (2008) Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. Prostaglandins, leukotrienes, and essential fatty acids 79, 153-156 [PubMed:18973997] [show Abstract] Metabolic cascades involving arachidonic acid (AA) and docosahexaenoic acid (DHA) within brain can be independently targeted by drugs, diet and pathological conditions. Thus, AA turnover and brain expression of AA-selective cytosolic phospholipase A(2) (cPLA(2)), but not DHA turnover or expression of DHA-selective Ca(2+)-independent iPLA(2), are reduced in rats given agents effective against bipolar disorder mania, whereas experimental excitotoxicity and neuroinflammation selectively increase brain AA metabolism. Furthermore, the brain AA and DHA cascades are altered reciprocally by dietary n-3 polyunsaturated fatty acid (PUFA) deprivation in rats. DHA loss from brain is slowed and iPLA(2) expression is decreased, whereas cPLA(2) and COX-2 are upregulated, as are brain concentrations of AA and its elongation product, docosapentaenoic acid (DPA). Positron emission tomography (PET) has shown that the normal human brain consumes 17.8 and 4.6 mg/day, respectively, of AA and DHA, and that brain AA consumption is increased in Alzheimer disease patients. In the future, PET could help to determine how human brain AA or DHA consumption is influenced by diet, aging or disease. | Bourre JM (2004) Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. The journal of nutrition, health & aging 8, 163-174 [PubMed:15129302] [show Abstract] Among various organs, in the brain, the fatty acids most extensively studied are omega-3 fatty acids. Alpha-linolenic acid (18:3omega3) deficiency alters the structure and function of membranes and induces minor cerebral dysfunctions, as demonstrated in animal models and subsequently in human infants. Even though the brain is materially an organ like any other, that is to say elaborated from substances present in the diet (sometimes exclusively), for long it was not accepted that food can have an influence on brain structure, and thus on its function. Lipids, and especially omega-3 fatty acids, provided the first coherent experimental demonstration of the effect of diet (nutrients) on the structure and function of the brain. In fact the brain, after adipose tissue, is the organ richest in lipids, whose only role is to participate in membrane structure. First it was shown that the differentiation and functioning of cultured brain cells requires not only alpha-linolenic acid (the major component of the omega-3, omega3 family), but also the very long omega-3 and omega-6 carbon chains (1). It was then demonstrated that alpha-linolenic acid deficiency alters the course of brain development, perturbs the composition and physicochemical properties of brain cell membranes, neurones, oligodendrocytes, and astrocytes (2). This leads to physicochemical modifications, induces biochemical and physiological perturbations, and results in neurosensory and behavioural upset (3). Consequently, the nature of polyunsaturated fatty acids (in particular omega-3) present in formula milks for infants (premature and term) conditions the visual and cerebral abilities, including intellectual. Moreover, dietary omega-3 fatty acids are certainly involved in the prevention of some aspects of cardiovascular disease (including at the level of cerebral vascularization), and in some neuropsychiatric disorders, particularly depression, as well as in dementia, notably Alzheimer's disease. Recent results have shown that dietary alpha-linolenic acid deficiency induces more marked abnormalities in certain cerebral structures than in others, as the frontal cortex and pituitary gland are more severely affected. These selective lesions are accompanied by behavioural disorders more particularly affecting certain tests (habituation, adaptation to new situations). Biochemical and behavioural abnormalities are partially reversed by a dietary phospholipid supplement, especially omega-3-rich egg yolk extracts or pig brain. A dose-effect study showed that animal phospholipids are more effective than plant phospholipids to reverse the consequences of alpha-linolenic acid deficiency, partly because they provide very long preformed chains. Alpha-linolenic acid deficiency decreases the perception of pleasure, by slightly altering the efficacy of sensory organs and by affecting certain cerebral structures. Age-related impairment of hearing, vision and smell is due to both decreased efficacy of the parts of the brain concerned and disorders of sensory receptors, particularly of the inner ear or retina. For example, a given level of perception of a sweet taste requires a larger quantity of sugar in subjects with alpha-linolenic acid deficiency. In view of occidental eating habits, as omega-6 fatty acid deficiency has never been observed, its impact on the brain has not been studied. In contrast, omega-9 fatty acid deficiency, specifically oleic acid deficiency, induces a reduction of this fatty acid in many tissues, except the brain (but the sciatic nerve is affected). This fatty acid is therefore not synthesized in sufficient quantities, at least during pregnancy-lactation, implying a need for dietary intake. It must be remembered that organization of the neurons is almost complete several weeks before birth, and that these neurons remain for the subject's life time. Consequently, any disturbance of these neurons, an alteration of their connections, and impaired turnover of their constituents at any stage of life, will tend to accelerate ageing. The enzymatic activities of sytivities of synthesis of long-chain polyunsaturated fatty acids from linoleic and alpha-linolenic acids are very limited in the brain: this organ therefore depends on an exogenous supply. Consequently, fatty acids that are essential for the brain are arachidonic acid and cervonic acid, derived from the diet, unless they are synthesized by the liver from linoleic acid and alpha-linolenic acid. The age-related reduction of hepatic desaturase activities (which participate in the synthesis of long chains, together with elongases) can impair turnover of cerebral membranes. In many structures, especially in the frontal cortex, a reduction of cervonic and arachidonic acids is observed during ageing, predominantly associated with a reduction of phosphatidylethanolamines (mainly in the form of plasmalogens). Peroxisomal oxidation of polyunsaturated fatty acids decreases in the brain during ageing, participating in decreased turnover of membrane fatty acids, which are also less effectively protected against peroxidation by free radicals. | Samuelsson B, Dahlén SE, Lindgren JA, Rouzer CA, Serhan CN (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science (New York, N.Y.) 237, 1171-1176 [PubMed:2820055] [show Abstract] Arachidonic acid is released from membrane phospholipids upon cell stimulation (for example, by immune complexes and calcium ionophores) and converted to leukotrienes by a 5-lipoxygenase that also has leukotriene A4 synthetase activity. Leukotriene A4, an unstable epoxide, is hydrolyzed to leukotriene B4 or conjugated with glutathione to yield leukotriene C4 and its metabolites, leukotriene D4 and leukotriene E4. The leukotrienes participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. Recent studies also suggest a neuroendocrine role for leukotriene C4 in luteinizing hormone secretion. Lipoxins are formed by the action of 5- and 15-lipoxygenases on arachidonic acid. Lipoxin A causes contraction of guinea pig lung strips and dilation of the microvasculature. Both lipoxin A and B inhibit natural killer cell cytotoxicity. Thus, the multiple interaction of lipoxygenases generates compounds that can regulate specific cellular responses of importance in inflammation and immunity. |
|